Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Whole exome sequencing in the UK Biobank reveals risk gene SLC2A1 and biological insights for major depressive disorder

Ruoyu Tian, View ORCID ProfileTian Ge, View ORCID ProfileJimmy Z. Liu, View ORCID ProfileMax Lam, Biogen Biobank team, View ORCID ProfileDaniel F. Levey, View ORCID ProfileJoel Gelernter, View ORCID ProfileMurray B. Stein, View ORCID ProfileEllen A. Tsai, View ORCID ProfileHailiang Huang, View ORCID ProfileTodd Lencz, View ORCID ProfileHeiko Runz, View ORCID ProfileChia-Yen Chen
doi: https://doi.org/10.1101/2021.05.04.21256398
Ruoyu Tian
1Translational Biology, Research and Development, Biogen Inc., Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tian Ge
2Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
3Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
4Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tian Ge
Jimmy Z. Liu
1Translational Biology, Research and Development, Biogen Inc., Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jimmy Z. Liu
Max Lam
4Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
5Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA
6Institute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Max Lam
1Translational Biology, Research and Development, Biogen Inc., Cambridge, MA, USA
Daniel F. Levey
7Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
8VA Connecticut Healthcare Center, West Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel F. Levey
Joel Gelernter
8VA Connecticut Healthcare Center, West Haven, CT, USA
9Departments of Psychiatry, Genetics, and Neuroscience, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joel Gelernter
Murray B. Stein
10VA San Diego Healthcare System, San Diego, CA, USA
11Department of Psychiatry, University of California San Diego, La Jolla, CA, USA
12Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Murray B. Stein
Ellen A. Tsai
1Translational Biology, Research and Development, Biogen Inc., Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ellen A. Tsai
Hailiang Huang
4Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
13Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
14Department of Medicine, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hailiang Huang
Todd Lencz
5Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA
6Institute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY, USA
15Departments of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Todd Lencz
Heiko Runz
1Translational Biology, Research and Development, Biogen Inc., Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Heiko Runz
  • For correspondence: chiayenc@gmail.com heiko.runz@gmail.com
Chia-Yen Chen
1Translational Biology, Research and Development, Biogen Inc., Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chia-Yen Chen
  • For correspondence: chiayenc@gmail.com heiko.runz@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Nearly two hundred common-variant depression risk loci have been identified by genome-wide association studies (GWAS)1–4. However, the impact of rare coding variants on depression remains poorly understood. Here, we present the largest to date exome analysis of depression based on 320,356 UK Biobank participants. We show that the burden of rare disruptive coding variants in loss-of-function intolerant genes is significantly associated with depression risk. Among 30 genes with false discovery rate (FDR) <0.1, SLC2A1, a blood-brain barrier glucose transporter underlying GLUT1 deficiency syndrome5–7, reached exome-wide significance (P=2.96e-7). Gene-set enrichment supports neuron projection development and muscle activities2, 3 as implicated in depression. Integrating exomes with polygenic risk revealed additive contributions from common and rare variants to depression risk. The burden of rare disruptive coding variants for depression overlapped with that of developmental disorder, autism and schizophrenia. Our study provides novel insight into the contribution of rare coding variants on depression and genetic relationships across developmental and psychiatric disorders.

Competing Interest Statement

R.T., E.A.T, H.R. and C.C. are employees of Biogen. J.Z.L. is an employee of GlaxoSmithKline plc.

Funding Statement

We did not receive any external funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Collection of the UK Biobank (UKBB) data was approved by the UKBB's Research Ethics Committee. UKBB individual-level, phenotypic data and whole exome sequencing data used in the present work were obtained under application ID 26041. The complete whole exome sequencing data used in this study will be publicly available once the embargoes have lifted (expected 2021). Patients and control subjects in FinnGen provided informed consent for biobank research, based on the Finnish Biobank Act. Alternatively, separate research cohorts, collected prior the Finnish Biobank Act came into effect (in September 2013) and start of FinnGen (August 2017), were collected based on study-specific consents and later transferred to the Finnish biobanks after approval by Fimea, the National Supervisory Authority for Welfare and Health. Recruitment protocols followed the biobank protocols approved by Fimea. The Coordinating Ethics Committee of the Hospital District of Helsinki and Uusimaa (HUS) approved the FinnGen study protocol Nr HUS/990/2017. The FinnGen study is approved by Finnish Institute for Health and Welfare (permit numbers: THL/2031/6.02.00/2017, THL/1101/5.05.00/2017, THL/341/6.02.00/2018, THL/2222/6.02.00/2018, THL/283/6.02.00/2019, THL/1721/5.05.00/2019, THL/1524/5.05.00/2020, and THL/2364/14.02/2020), Digital and population data service agency (permit numbers: VRK43431/2017-3, VRK/6909/2018-3, VRK/4415/2019-3), the Social Insurance Institution (permit numbers: KELA 58/522/2017, KELA 131/522/2018, KELA 70/522/2019, KELA 98/522/2019, KELA 138/522/2019, KELA 2/522/2020, KELA 16/522/2020 and Statistics Finland (permit numbers: TK-53-1041-17 and TK-53-90-20). The Biobank Access Decisions for FinnGen samples and data utilized in FinnGen Data Freeze 6 include: THL Biobank BB2017_55, BB2017_111, BB2018_19, BB_2018_34, BB_2018_67, BB2018_71, BB2019_7, BB2019_8, BB2019_26, BB2020_1, Finnish Red Cross Blood Service Biobank 7.12.2017, Helsinki Biobank HUS/359/2017, Auria Biobank AB17-5154, Biobank Borealis of Northern Finland_2017_1013, Biobank of Eastern Finland 1186/2018, Finnish Clinical Biobank Tampere MH0004, Central Finland Biobank 1-2017, and Terveystalo Biobank STB 2018001. Meta-analysis of depression by PGC (without UK Biobank and 23andme participants) is available at https://www.med.unc.edu/pgc/download-results/mdd/. Summary statistics of GWAS on individuals with European ancestry from Million Veteran Program (MVP) cohort was obtained through MVP Project Proposal MVP200097.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All phenotypic and genotypic data for the UK Biobank are available to researchers under data access request from the UK Biobank data access process (https://www.ukbiobank.ac.uk/enable-your-research/register). 454,787 whole exome sequencing data is not publicly available yet. Depression GWAS summary statistics from FinnGen Release 6 is not publicly available. Meta-analysis of depression by PGC (without UK Biobank and 23andme participants) is available at https://www.med.unc.edu/pgc/download-results/mdd/. Summary statistics of GWAS on individuals with European ancestry from Million Veteran Program (MVP) cohort was obtained through MVP Project Proposal MVP200097. pLoF Metrics is available at https://storage.googleapis.com/gcp-public-data--gnomad/release/2.1.1/constraint/gnomad.v2.1.1.lof_metrics.by_gene.txt.bgz. eQTLGen cis-eQTL summary statistics is available at https://www.eqtlgen.org/. Human protein atlas is available at https://www.proteinatlas.org/humanproteome/brain/human+brain. Drug gene interaction database is available at https://www.dgidb.org/.

https://www.ukbiobank.ac.uk/enable-your-research/register

https://www.med.unc.edu/pgc/download-results/mdd/

https://storage.googleapis.com/gcp-public-data--gnomad/release/2.1.1/constraint/gnomad.v2.1.1.lof_metrics.by_gene.txt.bgz

https://www.eqtlgen.org/

https://www.proteinatlas.org/humanproteome/brain/human+brain

https://www.dgidb.org/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 09, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Whole exome sequencing in the UK Biobank reveals risk gene SLC2A1 and biological insights for major depressive disorder
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Whole exome sequencing in the UK Biobank reveals risk gene SLC2A1 and biological insights for major depressive disorder
Ruoyu Tian, Tian Ge, Jimmy Z. Liu, Max Lam, Biogen Biobank team, Daniel F. Levey, Joel Gelernter, Murray B. Stein, Ellen A. Tsai, Hailiang Huang, Todd Lencz, Heiko Runz, Chia-Yen Chen
medRxiv 2021.05.04.21256398; doi: https://doi.org/10.1101/2021.05.04.21256398
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Whole exome sequencing in the UK Biobank reveals risk gene SLC2A1 and biological insights for major depressive disorder
Ruoyu Tian, Tian Ge, Jimmy Z. Liu, Max Lam, Biogen Biobank team, Daniel F. Levey, Joel Gelernter, Murray B. Stein, Ellen A. Tsai, Hailiang Huang, Todd Lencz, Heiko Runz, Chia-Yen Chen
medRxiv 2021.05.04.21256398; doi: https://doi.org/10.1101/2021.05.04.21256398

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (135)
  • Cardiovascular Medicine (1749)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (654)
  • Epidemiology (10785)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2935)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1919)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12501)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (322)
  • Neurology (2785)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1458)
  • Ophthalmology (441)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2633)
  • Public and Global Health (5342)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (724)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)